TGFB1 and head and neck squamous cell carcinoma: Finally, we showed that TGFβ inhibition in HNSCC cultured cells and can increase sensitivity to cisplatin treatment, and that patient HNSCC tumors that progressed after treatment were enriched in a transcriptional signature of cell quiescence.